Reich & Binstock
Free Initial Consultation Call
713-352-7883
713-352-7883

Defective Drugs Archives

Studies published on SSRI antidepressants and birth defects

A pair of respected medical journals published studies within the last couple of months that linked the expectant mother's use of selective serotonin reuptake inhibitor antidepressants with certain birth defects. The findings were released while SSRI antidepressant lawsuits have been filed against the makers of some of these popular drugs. Plaintiffs alleged the birth defects connection.

Study suggests simple way to improve chemo drug performance

Chemotherapy is a powerful tool in the fight against many different forms of cancer. The problem with it is that the chemicals that are used can be deadly. Doctors don't want to give patients too much of the stuff. If they do, the intended cure could be worse than the disease.

Study suggests simple way to improve chemo drug performance

Chemotherapy is a powerful tool in the fight against many different forms of cancer. The problem with it is that the chemicals that are used can be deadly. Doctors don't want to give patients too much of the stuff. If they do, the intended cure could be worse than the disease.

New studies released on Xarelto bleeding

Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.

New studies released on Xarelto bleeding

Medical science and countless victims have known all about the risks of gastrointestinal bleeding associated with the anticoagulant Xarelto (rivaroxaban). The bleeding risk is at the center of Xarelto lawsuits that are being filed across the nation by bleeding victims or by their surviving next-of-kin who have sought legal counsel and who have decided not to suffer in silence. Nevertheless, a pair of studies published in 2015 focus - if you will - on eye bleeding.

Improving the way drugs are tested and marketed

Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.

Improving the way drugs are tested and marketed

Sometimes there is good news and not-so-good news in a trial that tests the effectiveness and safety of a potential new drug. When the sponsor of the trial either downplays or disregards the unflattering information about an unreasonable health risk, it's the patient and the patient's family who get the worst news of all.

Recent science addresses Xarelto bleeding risk

Two professional journal articles released during the week of June 15 underscore the reason that patients who used the anticoagulant Xarelto suffered serious injury. Those scholarly pieces also somewhat vindicated victims or the family members of decedents who have filed Xarelto lawsuits.

Email Us For A Response

Contact Us For a Free Legal Consultation There is a never a fee unless we recover on your behalf.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Call for a Free Legal Consultation: 713-352-7883
Reich & Binstock - Pharmaceutical Injury & Class Action Lawyers

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Houston Law Office Map